A randomized trial of the effects of early cardiac serum marker availability on reperfusion therapy in patients with acute myocardial infarction
- 1 November 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 36 (5) , 1500-1506
- https://doi.org/10.1016/s0735-1097(00)00897-4
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- A Comparison of Thrombolytic Therapy with Primary Coronary Angioplasty for Acute Myocardial InfarctionNew England Journal of Medicine, 1996
- Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction.Circulation, 1994
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsPublished by Elsevier ,1994
- Randomised trial of late thrombolysis in patients with suspected acute myocardial infarctionThe Lancet, 1993
- Prehospital-Initiated vs Hospital-Initiated Thrombolytic TherapyJAMA, 1993
- Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarctionThe Lancet, 1993
- The Western Washington myocardial infarction registry and emergency department tissue plasminogen activator treatment trialThe American Journal of Cardiology, 1990
- Early detection of acute myocardial infarction in patients presenting with chest pain and nondiagnostic ECGs: Serial CK-MB sampling in the emergency departmentAnnals of Emergency Medicine, 1990
- Myocardial infarction triage and intervention project—Phase I: Patient characteristics and feasibility of prehospital initiation of thrombolytic therapyJournal of the American College of Cardiology, 1990
- Myoglobin as an early indicator of acute myocardial infarctionAnnals of Emergency Medicine, 1987